Related Experiment Videos
Mapping peptide antagonist binding sites of the human V1a and V2 vasopressin receptors
B Mouillac1, S Phalipou, N Cotte
1Unité INSERM 469 CCIPE, Montpellier, France.
Advances in Experimental Medicine and Biology
|February 23, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Time to re-envisage culturally responsive care: Intersection of participatory health research and implementation science.
Journal of advanced nursing·2023
The Emergent Architecture of Autonomous Clocks Described by Computational Algorithms of Regulatory Networks.
Advances in experimental medicine and biology·2026
Physical Frameworks and Theories on How Autonomous Biological Oscillators Synchronize.
Advances in experimental medicine and biology·2026
Leveraging Autonomous Biological Oscillators for Directed Evolution of Switchable Proteins.
Advances in experimental medicine and biology·2026
Synthetic Cell-Based Approaches to Dissect Autonomous Cellular Oscillators: Recent Applications on the Cell Cycle.
Advances in experimental medicine and biology·2026
Autonomous Oscillations of NF-κB.
Advances in experimental medicine and biology·2026
An Autonomous Clock that Controls Genetic Information Flow and Cellular Proteostasis.
Advances in experimental medicine and biology·2026
Open or closed? Structural characterization of plasma-derived and recombinant human plasminogen across multiple resolution scales.
International journal of biological macromolecules·2026
Emergency Department-Administered Extended-Release Buprenorphine After Fentanyl Overdose Reversed by Emergency Medical Services With Naloxone.
The Journal of emergency medicine·2026
[Advances in the application of Janus kinase inhibitors for the uncommon pediatric dermatological disorders].
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2026
Current perspectives in the pharmacological management of cutaneous and mucosal leishmaniasis.
Expert opinion on pharmacotherapy·2026